Clinical Trial Update: Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial [Phase 2]

View source ↗

Summary

RELAX is a Phase 2 randomized trial evaluating reduced length of androgen deprivation therapy and androgen receptor-targeted agent therapy with radiotherapy in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Tata Memorial Centre | Conditions: Prostate Carcinoma | Phase 2 | Status: RECRUITING